Manuscript Title: The title of manuscript should concisely, specific, relevant, informative and accurately specify the subject of your manuscript, it should not contain abbreviations.

Author Information: Author names must be listed in correct order, with affiliation is complete address information, including city, pin/zip code, state, and country. We encourage authors to include ORCID IDs, which will be requested on submission. Please indicate who the Corresponding Author is.

The corresponding author manages all pre- and post-publication communication for the manuscript, and must have their name, address, contact number, and email address clearly stated. Updated institutional email addresses and contact numbers for the corresponding author are required.

Abstract: The abstract should be informative and completely self-explanatory, briefly present the topic, state the scope of the experiments, indicate significant data, and point out major findings result and conclusion. The abstract should be no more than 300 words briefly specifying the aims of the work, the main results obtained, and the conclusions drawn.  Citations must not be included in the Abstract. Avoid using any abbreviated form in the abstract. Taxonomic authorities should not be used here.

Keywords: The abstract should be followed by 5 to 6 keywords. The keywords should indicate the main subject matter of your manuscript and will help potential readers to search for your manuscript.  

Manuscript Introduction: In this portion, the introduction should state why the study was carried out and what the specific aims of the study were. It should describe the background for the study (the available knowledge), its importance and its goals. It should be brief but complete enough for the reader to understand the reasons for the study without having to read previous publications on the subject.

Materials and Methods: This section should provide a complete overview of the Study Design, Study Duration, Study Place, Sample Size. Detailed descriptions of materials or participants, comparisons, interventions, and types of analysis should be mentioned. The detailed experimental protocols, techniques, instruments and software etc. used in the study should be described here with their proper references.

Results: The results section should provide a concise and precise description of the experiment results and data on all primary and secondary outcomes, identified in the materials and methods part. In the results should be include the findings of the study including, if appropriate, results of statistical analysis which must be included either in the text or as tables, graphs, flow charts, figures and all necessary pictures.

Discussion: The discussion should summarize how the study findings add to the current knowledge, provide explanations for the findings, compare the study’s findings with available studies, discuss the limitations of the study and the implications for future research. Authors should discuss the results and how they can be interpreted in perspective of previous work and of the working hypotheses.

Conclusions: In this section should state clearly the main conclusions and provide an explanation of the importance and relevance of the study. It determines the overall conclusions of the study and the future research directions

Acknowledgment: This section includes acknowledgment of people, grant details, funds, etc.

References: Only published or accepted manuscripts should be included in the reference list. Meetings abstracts, conference talks, or articles that have been submitted but not yet accepted should not be cited. All personal communications should be supported by a letter from the relevant authors. Authors are requested to provide at least one online link for each reference as follows (preferably PubMed).

For Example:

1. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circ Cardiovasc Interv. 2011;124:574- 651.

2. Inaba S, Mintz GS, Burke AP, Stone GW, Virmani R, Matsumura M, et al. Intravascular ultrasound and near- infrared spectroscopic characterization of thin-cap fibroatheroma. Am J Cardiol. 2017;119:372-8.

3. Liu X, Zhang Y, Xu Y, Tang Z, Wang X, Nie S, et al. Fractional flow reserve versus intravascular imaging to guide decision-making for percutaneous coronary intervention in intermediate lesions: A meta-analysis. Catheter Cardiovasc Interv. 2023;102:1198-209.

4. Sahin B, Ilgun G. Risk factors of deaths related to cardiovascular diseases in World Health Organization (WHO) member countries. Health & Social Care in the Community. 2022;30(1):73–80.

5. Gurbak I, Dervis E, Panç C, Sahin AA, Aslan S, Kahraman S, et al. The Effect of Recanalization of a Chronic Total Coronary Occlusion on Atrial Conduction Velocities. Acta Cardiol Sin. 2021 Jul;37(4):377–85.

Copyright Submission: Copyright Submission of a manuscript implies that the work described has not been published before (except in the form of an abstract or as part of a published lecture, or thesis) and that it is not under consideration for publication elsewhere. All submissions must be original, unpublished, and not under the review of any other publication.

All works published by the International Journal of Cardiology and Clinical Research (IJCCR) are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited.

Plagiarism: Manuscript Duplicity is a not allowed, thus Plagiarism should be completely avoided. Figures, Graphs, Pictures and Tables extracted from any sources are considered malpractice. The Data or Content extracted must be cited and this journal does not encourage the exact reproduction of any content.